D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.1 CNY -3.34% Market Closed
Market Cap: 18.7B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

Dizal Jiangsu Pharmaceutical Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Dizal Jiangsu Pharmaceutical Co Ltd stock under the Base Case scenario is 30.31 CNY. Compared to the current market price of 45.1 CNY, Dizal Jiangsu Pharmaceutical Co Ltd is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
30.31 CNY
Overvaluation 33%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
Dizal Jiangsu Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Dizal Jiangsu Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Dizal Jiangsu Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Dizal Jiangsu Pharmaceutical Co Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Dizal Jiangsu Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Dizal Jiangsu Pharmaceutical Co Ltd.

What unique competitive advantages
does Dizal Jiangsu Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Dizal Jiangsu Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide P/S
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide P/E
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide P/OCF
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide P/FCFE
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide P/B
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/S
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/GP
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/EBIT
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/OCF
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/FCFF
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide EV/IC
for Dizal Jiangsu Pharmaceutical Co Ltd.

Show me price targets
for Dizal Jiangsu Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Dizal Jiangsu Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Dizal Jiangsu Pharmaceutical Co Ltd?

What are the Net Income projections
for Dizal Jiangsu Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Dizal Jiangsu Pharmaceutical Co Ltd?

What are the EPS projections
for Dizal Jiangsu Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Dizal Jiangsu Pharmaceutical Co Ltd?

What are the EBIT projections
for Dizal Jiangsu Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Dizal Jiangsu Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Dizal Jiangsu Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dizal Jiangsu Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dizal Jiangsu Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dizal Jiangsu Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Dizal Jiangsu Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Dizal Jiangsu Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Dizal Jiangsu Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide ROE
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide ROA
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide ROIC
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide ROCE
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Gross Margin
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Operating Margin
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Net Margin
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide FCF Margin
for Dizal Jiangsu Pharmaceutical Co Ltd.

Show all solvency ratios
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide D/E Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide D/A Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Quick Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Current Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

Provide Cash Ratio
for Dizal Jiangsu Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Dizal Jiangsu Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Dizal Jiangsu Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Dizal Jiangsu Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dizal Jiangsu Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Dizal Jiangsu Pharmaceutical Co Ltd

Balance Sheet Decomposition
Dizal Jiangsu Pharmaceutical Co Ltd

Current Assets 910.4m
Cash & Short-Term Investments 748.2m
Receivables 85.5m
Other Current Assets 76.6m
Non-Current Assets 586m
PP&E 104.8m
Intangibles 462m
Other Non-Current Assets 19.2m
Current Liabilities 448.4m
Accounts Payable 108.9m
Accrued Liabilities 57.5m
Short-Term Debt 201.8m
Other Current Liabilities 80.2m
Non-Current Liabilities 199.3m
Long-Term Debt 187.2m
Other Non-Current Liabilities 12.1m
Efficiency

Earnings Waterfall
Dizal Jiangsu Pharmaceutical Co Ltd

Revenue
172.6m CNY
Cost of Revenue
-6.2m CNY
Gross Profit
166.4m CNY
Operating Expenses
-1.3B CNY
Operating Income
-1.1B CNY
Other Expenses
10.7m CNY
Net Income
-1.1B CNY

Free Cash Flow Analysis
Dizal Jiangsu Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Dizal Jiangsu Pharmaceutical Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Negative Operating Income
Negative Net Income
25/100
Profitability
Score

Dizal Jiangsu Pharmaceutical Co Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Dizal Jiangsu Pharmaceutical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
72/100
Solvency
Score

Dizal Jiangsu Pharmaceutical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Dizal Jiangsu Pharmaceutical Co Ltd

Wall Street analysts forecast Dizal Jiangsu Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dizal Jiangsu Pharmaceutical Co Ltd is 55.08 CNY with a low forecast of 54.54 CNY and a high forecast of 56.7 CNY.

Lowest
Price Target
54.54 CNY
21% Upside
Average
Price Target
55.08 CNY
22% Upside
Highest
Price Target
56.7 CNY
26% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Dizal Jiangsu Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dizal Jiangsu Pharmaceutical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Dizal Jiangsu Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Dizal Jiangsu Pharmaceutical Co Ltd

Country

China

Industry

Biotechnology

Market Cap

18.4B CNY

Dividend Yield

0%

Description

Dizal (Jiangsu) Pharmaceutical Co., Ltd. engages in the discovery, development, and commercialization of innovative medicines. The company is headquartered in Shanghai, Shanghai and currently employs 328 full-time employees. The company went IPO on 2021-12-10. The firm focuses on diseases such as malignant tumors and immune diseases. The main candidate innovative drugs in the Company's research and development (R&D) pipeline are DZD4205, DZD9008, DZD1516, DZD2269, DZD8586, DZD0095. The firm is still in the R&D stage.

Contact

SHANGHAI
Shanghai
Building 4, No. 199, 245 Liangjing Road, China (Shanghai) Pilot Free Trade Zone
+862161095757
www.dizalpharma.com

IPO

2021-12-10

Employees

328

Officers

Accounting Supervisor, CFO & Board Secretary
Mr. Lyu Hongbin M.B.A.
Deputy GM & Chief Scientist
Dr. Qingbei Zeng
Deputy GM & Chief Medical Officer
Dr. Zhenfan Yang M.D., Ph.D.
Deputy GM & Chief Commercial Officer
Ms. Qingyi Wu
Deputy GM & VP of Chemistry, Manufacturing and Control
Dr. Shih-Ying Chang Ph.D.
Senior Director
Mr. Kan Chen
Show More
Deputy General Manager
Ms. Suqin Chen
Vice President
Mr. Weijun Qiao
Show Less

See Also

Discover More
What is the Intrinsic Value of one Dizal Jiangsu Pharmaceutical Co Ltd stock?

The intrinsic value of one Dizal Jiangsu Pharmaceutical Co Ltd stock under the Base Case scenario is 30.31 CNY.

Is Dizal Jiangsu Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 45.1 CNY, Dizal Jiangsu Pharmaceutical Co Ltd is Overvalued by 33%.

Back to Top